Is Elevance Health (ELV) Trading at an Attractive Valuation?

1 month ago 23

Soumya Eswaran

Tue, February 10, 2026 astatine 7:00 AM CST 3 min read

Ruane, Cunniff LP, an concern advisor managing Sequoia Strategy, released its Q4 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Sequoia Strategy returned 9% successful Q4 compared to 2.7% for the S&P 500 Index. The Strategy delivered a instrumentality of 21.9% successful 2025 versus 17.9% for the Index. In a twelvemonth characterized by some spot and volatility, the Strategy outperformed the Index. The steadfast strives to put successful high-quality, fundamentally and financially beardown businesses astatine tenable prices. The Strategy is concentrated portion it covers a wide scope of sectors, concern styles, and regions. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Sequoia Strategy highlighted stocks specified arsenic Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is simply a wellness benefits institution detracted from the Strategy's show successful the quarter. On February 9, 2026, Elevance Health, Inc. (NYSE:ELV) banal closed astatine $327.50 per share. One-month instrumentality of Elevance Health, Inc. (NYSE:ELV) was -11.65%, and its shares are down 16.29% implicit the past 12 months. Elevance Health, Inc. (NYSE:ELV) has a marketplace capitalization of $72.281 billion.

Sequoia Strategy stated the pursuing regarding Elevance Health, Inc. (NYSE:ELV) successful its 4th fourth 2025 capitalist letter:

"Our investments successful UnitedHealth Group Inc. (“United”) and Elevance Health, Inc. (NYSE:ELV) (“Elevance”), the 2 largest managed attraction companies successful the country, are instructive successful this regard. We initiated some positions opportunistically. In the lawsuit of United, we capitalized connected a 2019 stock terms swoon precipitated by “Medicare for All” fears that flared up successful the runup to the 2020 statesmanlike election. We bought our archetypal shares of Elevance 2 years aboriginal erstwhile Covid induced swings successful healthcare utilization pressured its earnings.